Louis M. Weiner, MD
THE NATIONAL ACADEMY OF INVENTORS (NAI) has named Louis M. Weiner, MD, Director of the Georgetown Lombardi Comprehensive Cancer Center, to its 2018 class of fellows. According to the National Academy of Inventors, election to NAI Fellow status is the “highest professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society.” The 2018 NAI fellows will be inducted at the Space Center Houston in April 2019 at the 8th Annual Meeting of the National Academy of Inventors.
“I am inspired by the accomplishments of my 2018 NAI fellows and am humbled to join this class of fine scientists,” said Dr. Weiner, Professor and Chair of the Department of Oncology. “The NAI’s goal of recognizing and encouraging inventions for the betterment of human health makes this a special honor.” Dr. Weiner also serves as Director of the MedStar Georgetown Cancer Institute and is board-certified in internal medicine and medical oncology.
A medical oncologist specializing in the treatment of gastrointestinal cancers, Dr. Weiner is also a researcher developing novel immunotherapy treatments in his laboratory. He is recognized for his laboratory and clinical research focusing on monoclonal antibodies. His current work focuses on understanding why tumors become resistant to therapy using monoclonal antibodies and other forms of cancer immunotherapy, with the goal of developing new treatments to overcome that resistance. ■
